During biosynthesis on the ribosome, an elongating nascent polypeptide chain can begin to fold, in a process that is central to all living systems. Detailed structural studies of co-translational protein folding are now beginning to emerge; such studies were previously limited, at least in part, by the inherently dynamic nature of emerging nascent chains, which precluded most structural techniques. nMr spectroscopy is able to provide atomic-resolution information for ribosome-nascent chain complexes (rncs), but it requires large quantities (≥10 mg) of homogeneous, isotopically labeled rncs. Further challenges include limited sample working concentration and stability of the rnc sample (which contribute to weak nMr signals) and resonance broadening caused by attachment to the large (2.4-MDa) ribosomal complex. Here, we present a strategy to generate isotopically labeled rncs in Escherichia coli that are suitable for nMr studies. uniform translational arrest of the nascent chains is achieved using a stalling motif, and isotopically labeled rncs are produced at high yield using high-cell-density E. coli growth conditions. Homogeneous rncs are isolated by combining metal affinity chromatography (to isolate ribosome-bound species) with sucrose density centrifugation (to recover intact 70s monosomes). sensitivity-optimized nMr spectroscopy is then applied to the rncs, combined with a suite of parallel nMr and biochemical analyses to cross-validate their integrity, including rnc-optimized nMr diffusion measurements to report on ribosome attachment in situ. comparative nMr studies of rncs with the analogous isolated proteins permit a highresolution description of the structure and dynamics of a nascent chain during its progressive biosynthesis on the ribosome.
IntroDuctIon
An emerging nascent polypeptide chain is extruded from the ribosome from its N to C terminus, and it is able to adopt its biologically active structure in a co-translational manner 1, 2 . This process has been explored kinetically through biochemical studies, including pulse-chase investigations that are typically coupled to observations of proteolytic cleavage 3 or disulfide bond detection 4 , which show that protein folding on the ribosome can be coupled to translation on a biological time scale. However, a high-resolution understanding of how emerging nascent chains may adopt conformations on the ribosome has been largely underpinned by biochemical and biophysical experiments carried out on RNCs. Key to these latter studies is the ability to achieve selective and uniform translational arrest using peptidic motifs; these motifs directly interact with the ribosome 5 during biosynthesis to stably retain a nascent chain of uniform length relative to 3′-truncated nonstop mRNA 6, 7 . In the case of 70S ribosomes from E. coli, peptidic motifs derived from the E. coli proteins TnaC 8 and SecM 1, [9] [10] [11] [12] have been successfully exploited to produce homogeneous RNCs by generating thermodynamic equilibrium snapshots of the growing nascent chain at different stages of its biosynthesis 10 . Although the conformational preferences of an emerging nascent chain will be under kinetic control, where rates of translation compete with rates of folding, the use of stalled RNCs has enabled important advances in our understanding of their acquisition of biologically active structure 13, 14 . This has typically been reported using biochemical approaches, including antibody recognition studies 15, 16 and limited proteolysis 17 in studies of several multidomain proteins [18] [19] [20] [21] . Fluorescent resonance energy transfer (FRET) studies of RNCs have been particularly fruitful in exploring nascent chain emergence and folding, highlighted in the study of an N-terminal domain of HemK, which was shown to sample a compact state before adopting its fold 22 , and the demonstration of sequential formation of subdomains within NBD1 of the multidomain protein CFTR 7 . FRET 23 has also been central to the examination of early chain compaction within the exit tunnel, as has the development of cysteine-mass tagging PEGylation experiments 18 ; together, data generated by these techniques have suggested that nascent chains are able to form rudimentary structures such as α-helices and β turns 23, 24 as they traverse the ribosomal exit tunnel.
That differences exist between co-translational folding and the reversible folding of isolated proteins was initially well illustrated in the cases of firefly luciferase 18 and tailspike protein 19 : as isolated proteins, they are unable to fold reversibly from a chemically denatured state, yet as RNCs, they showed the capacity to adopt native structure co-translationally during progressive emergence on the ribosome. It has been suggested that the efficiency of folding on the ribosome may be partly influenced by the effects of the ribosomal surface 25, 26 , as marked differences in folding rates have been observed in optical tweezer experiments of T4 lysozyme RNCs 25 . The distribution of synonymous and nonsynonymous codons 21, 27 in the mRNA sequence has also been shown to alter the rate of nascent chain biosynthesis and, concomitantly, the rate and efficiency of folding 7, 28, 29 . The emerging nascent chain encounters a range of ribosome-associated auxiliary factors in the crowded cellular environment, the most pertinent for co-translational folding being the molecular chaperone trigger factor 4, 30, 31 , whose proposed interactions are both nascent chain length and sequence dependent and are likely to shape the folding landscape available to the nascent chain.
Despite the possible influences that co-translational folding events may have in promoting efficient folding, a structural understanding of how this process is achieved on the ribosome is lacking. Underpinned by comprehensive studies of the functional ribosome using X-ray crystallography and cryo-electron microscopy (cryo-EM) 9 ,32-37 , high-resolution structural studies of RNCs using cryo-EM 8, 9, 38 and NMR spectroscopy 1, 10, [39] [40] [41] [42] are beginning to provide more detailed structural descriptions of the conformations sampled by ribosome-bound nascent chains. Cryo-EM reconstructions of RNCs have in some cases, for example, revealed nascent chain compaction and α-helix formation within the ribosomal exit tunnel 38 and, more recently, the formation of a simple tertiary motif 43 . The steric restrictions imposed by the ribosomal exit tunnel 34 , however, cause the tertiary structure to form only beyond the tunnel in the majority of cases, at which point the dynamic nature of the ribosome-bound nascent chain impedes its observation via cryo-EM. A structural understanding of the nascent chain remains experimentally challenging because of its inherently dynamic character, and studies of such conformations are only possible through the use of NMR spectroscopy 10, 39, 40 , which is a technique uniquely poised to offer both structural and dynamical information. Indeed, despite the large molecular weight (2.4 MDa) of the 70S ribosome complex, which contributes to significant broadening of the majority of its NMR signals 44, 45 , ribosome-bound nascent chains display comparatively sharp and intense resonances such that detailed systematic structural studies of nascent chain folding on the ribosome are now emerging 1, 10, 39, 40 . These have been made possible by advances in preparative biochemistry methods for the production of large quantities of homogeneous RNCs. In vitro transcription-translation strategies 9, 39 , but also the more recently developed in vivo approaches using selective and uniform translational arrest, have enabled the production of isotopically labeled RNCs specifically for NMR studies 10, 46 .
Much of our current understanding of co-translational folding has been derived from biochemical and biophysical studies of RNCs, which offer the advantage over NMR studies in that they can report on kinetic rates as monitored in real time; however, structural changes are typically inferred from single-site fluorescence probes on the nascent chain or through nascent chain interactions with reporter molecules. NMR spectroscopy of RNCs has, therefore, a significant advantage in its ability to directly report upon structure while describing co-translational protein folding at a residue-specific level. Its ability to report on the highly dynamic nascent chain beyond the ribosomal tunnel means that it is uniquely positioned to complement structural techniques such as cryo-EM to generate a high-resolution understanding of structure formation as it occurs during biosynthesis.
Here, we present an approach that can be used to describe conformations adopted by nascent chains during translation, based on methods used in our laboratory in studies of over 50 nascent chain samples of varying length and sequences; our studies of an lg-fold 1, 10, 39, 40, 42, 47 , and of an intrinsically disordered polypeptide (α-synuclein 48 ), have been of particular value in developing our methodology. The protocol describes the in vivo production of isotopically labeled RNCs, which is a biochemical approach for sample characterization and a guide for NMR data acquisition and subsequent analysis in order to describe conformations adopted by nascent chains during translation. Rigorous approaches to monitoring sample integrity are also outlined. This protocol will serve as an essential foundation for detailed studies of co-translational folding, thus allowing an understanding of the conformational dynamics of a ribosome-bound nascent chain and serving to provide molecular restraints for molecular models at atomic resolution 1 .
Development of the procedure
We have designed an approach to produce homogeneous and isotopically labeled RNCs in vivo through the manipulation of E. coli growth to generate large quantities of translationally active ribosomes; this was achieved by using high-cell-density growth conditions adapted from autoinduction procedures 49 . The isolation of large amounts of translating ribosomes relies on well-established separation techniques-the sedimentation of ribosomal complexes using sucrose density ultracentrifugation 50 . We further adapted this technique for selection and purification of ribosome-bound nascent chains 10 at the high yields required for NMR spectroscopy relative to other structural and biophysical techniques; ~10 mg of material is required per NMR sample, which is roughly 2 to 3 orders of magnitude greater than that required for cryo-EM. We generate RNCs of different nascent chain lengths by varying the distance separating the protein of interest from the ribosome's peptidyl transferase center (PTC), thereby producing successive snapshots along the co-translational folding pathway and enabling us to monitor both unfolded and folded conformations using equilibrium measurements. By evaluating variables such as the sequence determinants and polypeptide-chain-length-dependent acquisition of structure during biosynthesis, we are developing structural models of co-translational protein folding.
NMR studies of RNCs are challenging for reasons that include the high viscosity of ribosomal solutions (with ideal working concentrations for NMR of ~10 µM, 24 mg/ml), but a significant limitation results from the inherent instability of the ribosomal complex, which is prone to degradation over extended periods of time. Ribosome-bound nascent chains can also be released from the ribosomal particle through mechanisms that include the overcoming of SecM stalling via spontaneous translocation 51, 52 or by the action of trace amounts of proteases. We have therefore adapted translational diffusion measurements from our NMR studies of ribosomes 44 to carefully monitor nascent chain integrity during NMR acquisition, and we complemented these with an orthogonal approach using biochemical assays to validate our observations.
The NMR strategy presented here should guide the reader toward the production of RNCs and detailed structural studies of co-translational folding events as they occur during biosynthesis on the ribosome, as we have undertaken for FLN5 (ref. 1, 10, 39, 40, 42) and α-synuclein 48 . Combining NMR of RNCs with comparative studies of the analogous isolated proteins provides the means to understand the manner in which the ribosome modulates folding within living systems. expression vector with a translational arrest motif-, such as a pLDC-17 vector 10 (Fig. 1) , and an N-terminal purification tag, such as a His tag. For the production of isotopically labeled RNCs (Fig. 1) , high-cell-density cultures of E. coli are grown (typically 0.5-2 l), to which isotopes are added at the induction of protein expression 10 , in order to confine labeling to the nascent chain. For purification of the RNCs (Fig. 1) , the E. coli cells are lysed and the RNCs are recovered using a combination of purification methods involving, for example, metal affinity chromatography to an N-terminal tag (for His-tagged RNCs) and sucrose density centrifugation (Fig. 2a) . Biochemical analyses of the purified RNCs using SDS-PAGE and western blot analyses (Figs. 1 and 2b-d) evaluate the homogeneity and integrity of the samples. NMR experiments on RNCs (Fig. 1) are typically performed using sample concentrations close to 10 µM, as the 70S complexes are less stable at higher concentrations and the associated increases in sample viscosity have an impact on the observable NMR signal. A temperature is chosen that is suitable for the system in question; for example, reduced temperatures (e.g., 277 K, 283 K) favor sample stability and are desirable for the study of disordered conformations, as slower amide/water proton exchange results in increased signal intensity 53 . Reducing the temperature also minimizes the background signal contribution from the globular ribosomal protein bL12. By contrast, higher temperatures (e.g., 298 K) have the effect of decreasing the correlation times of folded proteins and therefore improving their NMR observability, but increasing the temperatures to 310 K results in severe ribosomal degradation over short periods (minutes to hours). The exact parameters chosen for data acquisition therefore require consideration, as further outlined in Box 1, to maximize the observable signal and the quality of the data. Typically for RNCs, heteronuclear experiments are recorded in an interleaved manner with translational diffusion NMR experiments that report specifically on sample integrity (Fig. 1) . Indeed, RNC lifetimes can vary considerably depending on their structural properties and the temperature at which they are recorded (e.g., on the order of days at 277 K but only up to ~30 h at 298 K). Nascent chain degradation can significantly complicate the interpretation of RNC spectra, as the presence of a comparatively small population of released nascent chain can give rise to sharp and intense resonances because of its much shorter correlation time 39 .
The quality control analysis ( Figs. 1 and 3 ) of the ribosomal complex during NMR acquisition involves monitoring resonances corresponding to 70S ribosomal proteins in 1D experiments and those corresponding to the nascent chain in 2D experiments. NMR signals can be monitored over time; typically, an increase in intensity is interpreted as nascent chain release from the ribosome (which can be rationalized by the shortened correlation time that would be
Box 1 | Sensitivity versus resolution
The upper limit of the 70S ribosome particle working concentration is ~10 µM, which corresponds to a very high (24 mg/ml) concentration of 70S in solution. This concentration represents a major sensitivity challenge for modern biological NMR investigation, in particular when combined with the limited stability of RNCs in solution. In RNC NMR studies, it is crucial to optimize proposed NMR experiments in order to maximize the signal 70 . The sensitivity of 2D NMR experiments for a fixed total acquisition time and spectral resolution is determined by several factors (see inset figure): [NC] is the nascent chain concentration, T is the total acquisition time, B 0 is the magnetic field strength, T 2 is the transverse relaxation rate in the indirect dimension and t 1,max is the maximum evolution time in the indirect dimension, which is proportional to the frequency resolution. The nascent chain concentration [NC] is the limiting factor in determining the overall sensitivity. By contrast, there are diminishing returns for increases in the total acquisition time T, as a result of the T 1/2 dependence. The frequency resolution in the indirect dimension (as determined by the maximum evolution time, t 1,max ) is another key choice, as there is an inevitable compromise between sensitivity and resolution. We optimize t 1,max using the analogous isolated protein of the RNC system and, in the first instance, acquire 2D heteronuclear spectra for an uncharacterized RNC using the lowest acceptable resolution (i.e., t 1,max ) to maximize the overall NMR signal. Acquisition at higher field strengths is also likely to be beneficial as, in addition to the direct sensitivity gains due to the increased field strength, spectra can be acquired with identical chemical shift resolution (in p.p.m.) but with shorter evolution times (t 1,max and t 2,max ), thereby reducing relaxation losses. However, for some systems it is possible that chemical exchange-induced line broadening may reduce sensitivity of some resonances at higher fields. This should be assessed on a case-by-case basis, ideally using an isolated RNC analog, in order to determine the combination of field strength and evolution times that optimize sensitivity or resolution as required. In our experience, we have observed only positive effects on increasing the field strength from 700 to 950 MHz, and as 1.2 GHz fields are likely to become available in the next few years, the prospect of further improvements in sensitivity is encouraging. In addition, by implementing in advance an appropriate apodization function, the use of nonuniform weighted sampling methods can provide additional sensitivity improvements of 10-20%, without distortion of the resulting spectra 71 . Further recent developments include the use of soluble paramagnetic compounds that can be introduced into NMR samples, strongly accelerating longitudinal relaxation and hence increasing sensitivity at a cost of only little relative effect on transverse relaxation. This paramagnetic longitudinal relaxation enhancement (PLRE) effect has been shown to yield sensitivity gains of up to 85% on uniformly 15 N-labeled RNC samples when using the Ni(II) chelate NiDO2A 58 . Fig. 3b ) originate predominantly from the labile ribosomal bL12 protein [54] [55] [56] , and they can be used as an approximate measure of overall ribosomal integrity. Similarly, measurements of the nascent chain attachment to the ribosome are obtained using 15 N heteronuclear STE (XSTE) or 13 C-edited diffusion experiments, which directly probe the nascent chain. In cases in which the nascent chain may give rise to NMR signals that are too weak for diffusion measurements to be recorded within a suitable time frame, changes in the average 2D intensities of the nascent chain can be used to monitor sample stability. In parallel with NMR experiments, samples of the RNC collected throughout NMR acquisition are also probed using western blotting to evaluate the nascent chain integrity over time, using nascent-chain-specific antibodies against the N terminus (e.g., antiHis tag antibody) or the C terminus (e.g., SecM-stalling sequence). Ribosome-bound nascent chains typically migrate on SDS-PAGE with an additional 17-to 20-kDa band-shift relative to that of the expected molecular mass of the nascent chain; this is caused by the presence of a P-site peptidyl tRNA, which is covalently linked to the stalled nascent chain (Fig. 2c) . To distinguish intact RNCs from those that have been compromised by nascent chain release, we carry out PAGE using low pH conditions that preserve the nascent chain-tRNA ester bond. With these tools in hand, we are able to confidently report spectra of intact RNCs for structural analysis, including detailed analyses of resonance intensities and line widths, to explore the relaxation properties and mobility of the nascent chain. Together, these studies are used to describe differences between folding in bulk solution and on the ribosome.
Advantages and limitations
Our protocol presents a versatile in vivo approach using E. coli for the production of significant quantities of homogeneous RNCs, which can be adapted to incorporate isotopic labeling schemes as necessary for studies using NMR spectroscopy. The capacity to exploit E. coli in this manner enables the production of uniformly arrested RNCs comparable to those generated using in vitro translation methods, using routine biochemical reagents and at a relatively low cost. Although the use of stable isotopes for nascent chain labeling introduces a significant cost, it is arguably a reasonable compromise for the rich, residue-specific information that can be derived from a single RNC spectrum.
An important consideration in using an in vivo-based approach for isotopic labeling of RNCs, however, is the extent to which the labeling is confined to the nascent chain. Continuous ribosome biogenesis can result in background 70S ribosome labeling, which gives rise to resonances that correspond to the bL12 ribosomal stalk observable in 2D correlation spectra 44 alongside labeled nascent chains. Typically, however, the high-cell-density conditions during the induction of expression restrict cell growth (and thus ribosome biogenesis), and the use of rifampicin, which is an inhibitor of the bacterial host DNA polymerase, reduces the extent of bL12 isotopic labeling (by an additional ~10% in our experience). Our protocol also describes NMR measurements (Step 23) in order to quantify ribosome background labeling in samples that are uniformly 15 N-and/or 13 C-labeled.
The procedure has been designed to enable RNCs to be produced in a straightforward manner; however, the most significant challenges arise from the inherent complexities presented by the samples themselves during NMR studies. Notably, these include the low maximum achievable RNC concentrations, their Signal intensity (a.u.)
T im e ( h ) 15 N SOFAST HMQC at the start of acquisition (t = 0-8 h) and at the end of acquisition (t = 87-95 h), highlighting the appearance of folded FLN5 (circled), which we attribute to degradation of the sample through nascent chain release. Disordered FLN5 can also be detected in the central region of the spectrum at t = 87-95 h, which we attribute to proteolysis. All uncertainties have been derived from the spectral noise. a.u., arbitrary unit.
high molecular weight and the physical properties of the nascent chains themselves. This prompts the need for a careful choice of nascent chain system (see Experimental design), as well as NMR experimental design (Box 1), and complementary comparative studies with isolated protein. We anticipate that the continuous development of NMR strategies to enhance sensitivity, as well as the molecular biology of RNCs, will further improve the capacity to study co-translational folding in this manner.
Experimental design
Choosing a nascent chain system to study. For NMR studies of RNCs, a key factor is the choice of the nascent polypeptide to investigate, which is strongly influenced by the dynamic properties of the nascent chain and its interactions with the ribosome. Relative to the isolated polypeptide in bulk solution, the ribosome-attached nascent chain has decreased motional properties, which result in a reduction in its NMR signal and which can be diminished further by interactions between the nascent chain and the ribosomal surface, or by possible intrachain interactions. As NMR has the capacity to report on transient and/or weak interactions, any significant affinity between the nascent chain of interest and the ribosomal surface manifests as resonance broadening and/or changes in chemical shift.
Our protocol has, to date, been applied to polypeptides that inherently give rise to strong NMR signals (i.e., proteins of small size (<30 kDa) and/or of disordered nature) and to those that that show a high spectral quality in both their natively folded and unfolded forms, even in the presence of 70S ribosomes (Supplementary Fig. 1) . A characterization of the polypeptide of interest in isolation, in both its folded and unfolded forms (achieved, e.g., by mutation or C-terminal truncation), and in the presence of 70S ribosomes, is instructive of a suitable nascent chain choice for NMR investigation; it also forms an important basis for comparative analysis with RNCs. In addition, it is advantageous to choose a nascent chain system in which the polypeptide has biochemical properties that can be evaluated. A range of biochemical and biophysical strategies have been used to characterize ribosome-nascent chain complexes (e.g., enzymatic activity 14 , antibody recognition 15, 16 , limited proteolysis 17 and PEGylation 1,57 ), as well as to consider the unique influence of the cellular milieu during biosynthesis 21, 30, 31 . The use of combined approaches permits potential corroboration of the high-resolution NMR studies of RNCs with co-translational events as they take place within the cell.
Choice of isotopic labeling scheme. The choice of a suitable isotopic labeling scheme constitutes an important part of the experimental design to ensure optimal observability of the nascent chain, as shown in our studies of FLN5 RNCs 1, 10, 39, 40, 42, 58 . For the study of disordered conformations, 15 N labeling can take advantage of the large dispersion in the 15 N dimension, as its chemical shift is particularly sensitive to the local amino-acid sequence. 15 N spectra therefore typically resolve a larger number of resonances arising from disordered states as compared with other heteronuclei. In the study of globular states, 13 C labeling can typically provide the more sensitive probes that are needed to characterize the formation of tertiary structure. Observation of NMR spectra for globular nascent chains, presents additional challenges through reduced flexibility and proximity to the ribosomal particle 10 • EM9 salts Prepare a 100-ml solution by adding 10 ml of 70 g/l Na 2 HPO 4, 10 ml of 34 g/l KH 2 PO 4 and 10 ml of 5.8 g/l NaCl to H 2 O. Lysis buffer The lysis buffer is 1 M KOAc, 50 mM HEPES, 12 mM MgOAc, 5 mM EDTA, 5 mM ATP, 2 mM BME, 1 mg/ml lysozyme, DNase I and protease inhibitors (1 tablet per 100 ml), pH 7.5. Prepare a 100-ml solution by adding 20 ml of 5 M KOAc, 10 ml of 0.5 M HEPES, 4.8 ml of 0.25 M MgOAc, 1 ml of 0.5 M EDTA, 250 mg of ATP, 14 µl of BME, 100 mg of lysozyme and traces of DNase I to H 2 O. Adjust the pH of the solution using NaOH. Filter-sterilize the buffer and chill it to 4 °C before use.
Resuspension buffer
The resuspension buffer is 1 M KOAc, 50 mM HEPES, 12 mM MgOAc, 5 mM EDTA, 5 mM ATP and 2 mM BME, pH 7.5. Prepare a 100-ml solution by adding 20 ml of 5 M KOAc, 10 ml of 0.5 M HEPES, 4.8 ml of 0.25 M MgOAc, 1 ml of 0.5 M EDTA, 250 mg of ATP, 14 µl of BME to H 2 O. Adjust the pH of the solution using NaOH. Filter-sterilize the buffer and chill it to 4 °C before use. Washing buffer The washing buffer is 500 mM KOAc, 50 mM HEPES, 6 mM MgOAc and 2 mM BME, pH 7.5. Prepare a 500-ml solution by adding 50 ml of 5 M KOAc, 50 ml of 0.5 M HEPES, 12 ml of 0.25 M MgOAc and 70 µl of BME to H 2 O. Adjust the pH of the solution using NaOH. Filter-sterilize the buffer and chill it to 4 °C before use. Elution buffer The elution buffer is 500 mM KOAc, 50 mM HEPES, 6 mM MgOAc, 150 mM imidazole and 2 mM BME, pH 7.5. Prepare a 250-ml solution by adding 25 ml of 5 M KOAc, 25 ml of 0.5 M HEPES, 6 ml of 0.25 M MgOAc, 15 ml of 2.5 M imidazole and 35 µl of BME to H 2 O. Adjust the pH of the solution using HCl. Filter-sterilize the buffer and chill it to 4 °C before use. Sucrose buffers The sucrose buffers are two stock solutions of 35% and 10% (wt/vol) sucrose in 1 M KOAc, 50 mM HEPES, 12 mM MgOAc, 5 mM EDTA, 2 mM BME and 0.1/100 ml protease inhibitor tablet, pH 7.5. Prepare for each a 500-ml solution by adding 175 g (or 50 g) of sucrose, 100 ml of 5 M KOAc, 50 ml of 0.5 M HEPES, 24 ml of 0.25 M MgOAc, 5 ml of 0.5 M EDTA, 70 µl of BME and 0.5 protease inhibitor tablet to H 2 O. Adjust the pH of the solutions using NaOH. Filter-sterilize the buffers and chill them to 4 °C before use. Tico buffer The Tico buffer is 30 mM NH 4 Cl, 10 mM HEPES (or deuterated HEPES-D 12 ), 12 mM MgCl 2 , 1 mM EDTA, 2 mM BME and 0.1/100 ml protease inhibitor tablet, pH 7.5. Prepare a 100-ml solution by adding 2 ml of 0.5 M HEPES, 6 ml of 0.5 M NH 4 Cl, 2.4 ml of 0.5 M MgCl 2 , 0.2 ml of 0.5 M EDTA, 14 µl of BME and 0.1 protease inhibitor tablet to H 2 O. Adjust the pH of the solution using NaOH. Filter-sterilize the buffer and chill it to 4 °C before use. Low-pH loading dye Prepare 20 ml as shown below. Prepare 1-ml aliquots and store them at −20 °C (stable for years). 
Compound Amount Concentration

3|
Depending on the labeling strategy selected for a given nascent chain system (refer to Experimental design), isotopically label RNCs in vivo using E. coli according to option A, to achieve uniform labeling (EM9 medium can be adapted for, e.g., U-15 N or U-15 N/ 13 C labeling-see Reagent Setup), or option B, to achieve perdeuteration and selective labeling of methyl side chains. These two strategies can be used for implementing alternative labeling schemes. However, given the relative costs associated with isotopic labeling, it is likely that uniform labeling approaches (option A) would be considered initially, before more complex labeling schemes (e.g., option B).  crItIcal The growth kinetics of E. coli using deuterated media components are significantly slower (doubling time of 1-1.5 h or more); hence, the production time of RNCs using this strategy needs to be longer than that for protonated (e.g., 1 H-15 N) approaches. Here, the E. coli are first grown in deuterium oxide using protonated carbon sources, followed by deuterated carbon sources, before large-scale growth and expression; this generally improves the reliability of E. coli growth. (ii) Use the cells pelleted from the final adaptive stage at Step 3B(i) to prepare a 100-ml culture in perdeuterated MDG; grow them to saturation and centrifuge them as described in Step 3B(i). (iii) Use the cells pelleted from the culture in Step 3B(ii) to inoculate 500 ml of MDG; grow the cells using the conditions described in Step 3B(i). 
7|
Load the clarified supernatant onto an ice-cold 35% (wt/vol) sucrose cushion. Spin the sucrose cushion at 200,000g, for 4-12 h at 4 °C in an ultracentrifuge (Type 45Ti rotor, Beckman). Optional: retain the resulting supernatant to purify the released nascent chain if desired-e.g., to compare bound versus released nascent chains by NMR (e.g., using metal affinity chromatography as described in Steps 9-11).
8|
Gently resuspend the ribosomal pellet in resuspension buffer, and measure the ribosome concentration by OD 260nm (1 OD 260nm = 24 pmol/ml).  crItIcal step If you are using a pipette to resuspend the pellet, avoid excess bubble formation to minimize potential release of the nascent chain.
9|
Bind the ribosomal suspension to an appropriate metal affinity resin according to the manufacturer's instructions for 1 h at 4 °C.
10|
Wash the resin with washing buffer, according to the manufacturer's instructions, until the protein detected in the flow-through is negligible, as determined visually using a Bradford assay.
11|
Elute the RNC fraction with elution buffer, assessing when elution is complete, as described in Step 10 (typically 50-100 ml).
12| Concentrate the eluate in a 100-kDa-cutoff concentrator according to the manufacturer's instructions, to a 70S ribosome concentration of up to 10 nmol/ml (see Step 8) , at 3,000g and 4 °C.  crItIcal step For an accurate measure of the OD 260nm , the imidazole should be removed using the 100-kDa-cutoff concentrator and the imidazole concentration should be progressively diluted.
13|
Using a gradient former, pour 10-35% (wt/vol) sucrose gradients (35 ml, in 25 × 89 mm tubes) and load 1,500 pmol of the RNC from Step 12. Spin the gradients in an ultracentrifuge at 64,000g, for 16-18 h at 4 °C.
14|
Using a pump and fraction collector, fractionate the gradients (1.0-1.5 ml) and monitor elution using OD 254nm measurements. Run aliquots (15 µl) from each fraction on a 12% (wt/vol) polyacrylamide gel, and determine the presence and homogeneity of the 70S RNC peak (as shown in Fig. 2b) .
? trouBlesHootInG 15| Buffer-exchange the 70S-containing fractions using a 100-kDa-cutoff concentrator to dilute the sucrose content to the nanomolar concentration range using Tico buffer at 3,000g and 4 °C. Measure the absorbance of the RNCs at OD 260nm and OD 280nm to evaluate the 70S content (see Step 8) and its homogeneity using the OD 260/280nm ratio (expected range: 1.9-2.0) (ref. 65) . The resulting RNC sample can be used immediately, or it can be flash-frozen using liquid N 2 and stored at −80 °C.  pause poInt This sample can be stored at −80 °C for months.
Biochemical analysis of the purified rnc samples • tIMInG 2 d 16| Prepare or purchase neutral-pH gels with a polyacrylamide concentration that permits resolution of the nascent chain of interest and prepare the low-pH loading dye. ! cautIon Wear gloves when you are handling acrylamide, which is a neurotoxin.
17|
To assess the RNC integrity and nascent chain occupancy, load the polyacrylamide gels with 2-10 pmol samples of untreated RNC (from Step 15) and RNC (from Step 15) treated with 10 µg of RNase A to digest the rRNA (at room temperature for 5 min), along with a series of concentration standards of the isolated protein of interest.
18|
Using standard western blot procedures, transfer the gels onto a nitrocellulose membrane, probe them with an antibody that recognizes the RNC (e.g., anti-His, anti-SecM), and detect it using chemiluminescence 66 .  crItIcal step Minimize direct contact with the nitrocellulose membrane to avoid cross-contamination.
19|
Using ImageJ software, quantify the nascent chain occupancy by densitometry analysis: measure the intensity of the chemiluminescent signal arising from the isolated protein standards and generate a standard curve. Determine the concentration of nascent chain present in the RNase-A-treated RNCs using the standard curve of the isolated protein and the concentration of the RNCs (based upon the 70S concentration at OD 260nm ). Note that a similar procedure can be applied for detecting the presence of trigger factor and any other ribosome/nascent chain-associated proteins. 21| Transfer ~10% of the RNC sample to a separate tube and incubate it at the same temperature as used for NMR acquisition for the duration of NMR acquisition. Collect aliquots at regular intervals (e.g., hourly) for subsequent western blot analysis of RNC integrity over time (Box 2). .6-3.8 p.p.m.). Note the time frame during which the signals remain unchanged. We typically process the spectra in NMRPipe 62 and convert the data to a text-file format, and then we generate a stacked overlay using the MATLAB software.
22|
26| Analysis of the 1 H STE diffusion spectra to evaluate the translational diffusion. Process each 1 H STE diffusion spectrum.
Integrate the resonances arising from the ribosomal background (methyl region) for each of the gradient strengths and plot the integrated signal against the time of acquisition. Determine the noise level of the signal integral. This is the standard deviation calculated from integrated signals that have been randomly selected from 30 to 35 regions of identical bandwidth within the baseline of the spectra.
27|
Determine translational diffusion coefficients of the observed ribosomal resonances using the Stejskal-Tanner equation (1) for bipolar gradients 67, 68 , which relates the attenuation in signal at a given strength of the pulsed-field gradient to the diffusion coefficient D, where I and I 0 are the intensities at the two gradient strengths, γ is the 1 H gyromagnetic ratio (2.67522128 × 10 8 rad/s/T), σ is the shape factor (0.9 for a smooth square (SMSQ) gradient), ∆ is the diffusion delay (100 ms), δ is the length of the gradient pair (4 ms), G is the gradient strength, τ is the delay between gradient pulses in bipolar gradient pairs and D is the diffusion coefficient. Use either the ratio in intensities of 5% and 95% or 50% and 95% of the total gradient strength G in order to determine a value for the diffusion coefficient D.
28|
Determination of the period of ribosome stability. Using the 1 H 1D plots produced in Step 25, evaluate the methyl resonances arising over time from the ribosomal background protein, together with the plots of translational diffusion produced in Step 27. Determine the time frame during which these measurables remain unchanged, which reports on an intact 70S complex. 15 N XSTE (SORDID) spectra to determine the period of nascent chain attachment. Process each 13 C-edited STE/ 15 N XSTE/SORDID diffusion spectrum using NMRPipe software: repeat the analyses as described in Step 27, using gradient strengths 5% G and 95% G. (1) subsequent analysis. If the isolated protein has been assigned, identify the RNC resonances by spectral overlay and transfer assignments. Determine peak heights for the resonances of interest, as well as peak heights for any discrete ribosomal bL12 resonances.
29| Analysis of the 13 C-edited STE or
32|
Determine peak heights of (typically 100) randomly chosen positions in the same chemical shift range as the RNC resonances within a spectrum. The uncertainty of each intensity measurement in Step 31 is given by the standard deviation of the noise intensity measurements.
33|
Plot averaged peak heights of the resonances arising from the nascent chain and ribosomal protein bL12 over time.
Intensity changes are typically indicative of sample breakdown.
characterization of the structural and dynamical properties of the rnc • tIMInG 0.5 d 34| Once the time frame during which the RNC remains intact has been established by using the approaches in Steps 24-33, sum the corresponding heteronuclear correlation spectra. A residue-by-residue analysis of the heteronuclear spectra can be undertaken, using 2D correlation spectra by comparing spectra of the isolated protein in the presence of 70S ribosomes, as described in the Experimental design section.
? trouBlesHootInG Troubleshooting advice can be found in table 1. (Steps 2 and 3) , the cells are lysed (Steps 4 and 5) and the soluble cell lysate is subjected to a 35% (wt/vol) sucrose cushion, from which ~50-100 nmol of ribosomes can be recovered per liter of E. coli culture (Steps 6-8). The ribosomal suspension (a mixture of RNCs, empty 70S ribosomes, ribosomal subunits and released nascent chains) is applied to a metal affinity column, which recovers the fraction containing RNCs, resulting in 6,000-9,000 pmol of material (Steps 9-12). Further purification using a 10-35% (wt/vol) high-salt sucrose gradient permits the separation of other contaminating species, including ribosome-associated proteins (Steps 13 and 14 and Fig. 2a,b) . After purification, 3-6 nmol (7-15 mg) of RNCs can typically be purified to homogeneity per liter of culture, representing 6-18% of the total ribosomal population recovered from the cell lysate (Step 15). This value is representative of the overall purification yield rather than the extent of SecM translational arrest occurring in vivo, which may be significantly greater. Following these preparative steps, the degree of translational arrest in the purified sample, estimated using isolated protein standards of known concentrations, is typically observed to be >90% (Steps 16-19 and Fig. 2c,d) . Within the RNC sample, the extent of 70S background isotopic labeling is subsequently evaluated using a combination of 15 N (or 13 C) filtered 1D proton and edited 1D proton spectra, in which for the case of uniformly 15 N-labeled samples the intensity of the envelope of 14 N-bound protons arising from the ribosomal bL12 resonances (unlabeled amides) is compared against that of 15 N-bound protons (labeled amides); an analogous approach is used for uniformly 13 C-labeled samples (Step 23). We observe that typically 5-15% of the bL12 protein is isotopically labeled, and therefore overall ribosome background labeling of this magnitude contributes only minimally to heteronuclear experiments (supplementary Fig. 2 ). Variability in overall RNC yields relates to the nascent chain system and is thus considered on a case-by-case basis (see TROUBLESHOOTING table for details) .
To illustrate how we can use NMR to observe successive stages of the folding of an emerging nascent chain, here we show two RNC examples from our studies 1 of the biosynthesis of an immunoglobulin domain derived from the multidomain protein FLN. These RNCs mimic the progressive emergence and co-translational folding of FLN5, and they consist of FLN5 tethered to increasing numbers of residues of the subsequent domain, FLN6 (ref. 10) , and a SecM stalling sequence. In the FLN5+21 RNC construct, the FLN5 domain resides 21 residues from the PTC, which is in the vicinity of the ribosomal exit tunnel (Fig. 4a) . In FLN5+110 RNC, the nascent chain is separated by a significant distance (110 residues) from the PTC 1, 10 (Fig. 4b) . Resonances in 1 H-15 N correlation spectra of FLN5+21 RNC give rise to a narrow resonance dispersion in the 1 H dimension, consistent with a disordered conformation, whereas 1 H- 13 To ensure that these resonances arise from a ribosome-attached nascent chain, examination of both western blot and diffusion analyses is recommended (Box 2 and Steps 29 and 30). In the case of the disordered FLN5+21 RNC sample, western blot analyses reveal a significant change in the intensity of the tRNA-bound nascent chain band after t = 2.1 h (Fig. 4c) , as observed in the anti-His blot (top), and after t = 5.9 h in an anti-SecM blot (bottom). Similarly, 15 N XSTE diffusion data reveal changes in D beyond t = 2.1 h, suggesting that within this 2-h time frame the RNC is intact (Fig. 4e) . For the FLN5+110 RNC, both the anti-His and anti-SecM western blots (Fig. 4d) indicate that the tRNA-bound nascent chain remains stable throughout an NMR acquisition period of 17 h, beyond which NMR data are not included in the analysis. Indeed, lower-molecularweight bands that are observable in the anti-SecM blot at t = 32 h are consistent with truncation of the nascent chain. In addition, the diffusion coefficient, D, can also be determined from 13 C-edited STE experiments on discrete resonances arising exclusively from the nascent chain, and reports an intact RNC (D = 1.5 ± 0.3 × 10 −11 m 2 /s) until t = 17 h (Fig. 4f) . Generally, changes in the intensity of the tRNA-bound nascent chain band in excess of 10% of the original intensity are regarded as significant, as these could give rise to interfering NMR signals. These intensity changes are also often concomitant with the appearance of lower-molecular-weight bands that we attribute to nascent chain release (e.g., overcoming translational arrest or proteolysis) and an increase in the diffusion coefficient associated with the nascent chain resonances. The time frame during which the nascent chain is stable within a given RNC varies between sample preparations, and the integrity of each sample during the course of its NMR acquisition is therefore considered on an individual basis.
Structural NMR spectra (such as heteronuclear correlation spectra, RDC or dynamics data) reflecting intact RNCs are typically summed, and analysis of the structural and dynamical properties of the RNC is undertaken. In this example, the shortest nascent chain length, FLN5+21 RNC, shows disordered resonances in 1 H-15 N correlation spectra, which overlay closely with those of a corresponding disordered isolated variant (termed FLN5∆12, Fig. 4a ). This suggests similar conformations of the two samples and a disordered FLN5 nascent chain when the domain is close to the ribosomal exit tunnel. By contrast, once the linker length has increased to 110 residues, the resonances observed for [U-2 H]; Ileδ1-[ 13 CH 3 ]-labeled FLN5+110 RNC were found to overlay closely those of isolated natively folded FLN5. Four dispersed methyl resonances (corresponding to I738, I743, I674 and I695, within 0.01 p.p.m. in the 1 H dimension) can be identified, where I748 is discernible but overlaps in most spectra with resonances arising from the ribosomal stalk, resulting from background labeling (Fig. 4b) . These data demonstrate that FLN5+110 RNC adopts a native FLN5 fold.
These experiments have provided the foundation for examining 'structural snapshots' of a nascent chain during synthesis and folding on the ribosome. This will allow the determinants of co-translational protein folding and the influence of scenarios unique to the emerging nascent chain, including the vectorial emergence of the amino-acid sequence, the presence of the ribosome and the role of molecular chaperones, to be explored at a residue-specific level and at high resolution. 
